Tested laboratory quality >99% purity Fast & secure shipping
Go to homepage
€0.00
Skip image gallery
CJC-1295 / Ipamorelin Blend (5 mg / 5 mg) – Research peptide

CJC-1295 / Ipamorelin Blend (5 mg / 5 mg) – Research peptide

  • 🔬 Tested laboratory quality
  • 💎 >99% purity
  • 🚚 Fast & secure shipping

€74.99

Prices incl. VAT plus shipping costs

Available

Product number: UBL-017

Combined peptide formulation for studying synergistic signaling mechanisms in growth hormone release and receptor activation.

General Description

The CJC-1295 / Ipamorelin Blend combines two synthetic peptides used in scientific studies to analyze peptide-mediated secretion mechanisms. CJC-1295 is a modified GHRH analogue (Growth Hormone Releasing Hormone), while Ipamorelin is a synthetic GHRP agonist (Growth Hormone Releasing Peptide). Together, they serve as an experimental model for investigating parallel signaling pathways, receptor activation, and peptide synergy within endocrine systems.

Chemical Properties
  • Purity: ≥ 99 % (HPLC-tested)
  • Form: lyophilized powder
  • Content: 5 mg CJC-1295 + 5 mg Ipamorelin
  • Sequences:
    • CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
    • Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
  • Solubility: water-soluble after reconstitution
Research Relevance

In preclinical research models, the CJC-1295 / Ipamorelin Blend is used to study combined peptide signaling, receptor cascades, and endocrine feedback mechanisms. It is intended exclusively for fundamental research and the structural analysis of synergistic peptide effects at the molecular level.

Storage & Handling

Store in a cool (2 – 8 °C), dry place. After reconstitution, aliquot and store at −20 °C to preserve the stability of both peptide components.

Certificate of Analysis (COA)

Each batch of the CJC-1295 / Ipamorelin Blend is verified by HPLC and mass spectrometry analyses. The corresponding COA is available for download per batch.

Notice & Disclaimer

This product is intended for research purposes only. Not for human or animal use, and not suitable for diagnostic or therapeutic applications.

0 of 0 reviews

Leave a review!

Share your experiences with other customers.

Skip product gallery

You may also be interested in:

Tesamorelin (10 mg) – Research peptide
Tesamorelin (10 mg) – Research peptide
Synthetic GHRH analogue for studying endocrine signaling processes and secretion mechanisms in preclinical research models. General Description Tesamorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), developed to study receptor-mediated signaling pathways and secretion processes within endocrine regulation. In scientific research environments, Tesamorelin is used to analyze the molecular mechanisms of growth hormone release and peptide–receptor interaction. Through targeted sequence modifications, Tesamorelin demonstrates increased stability against enzymatic degradation and is suitable for the structural characterization of peptide-based signaling networks. Chemical Properties Purity: ≥ 99 % (HPLC-tested) Form: lyophilized powder Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ Molecular weight: approx. 5135 Da Solubility: water-soluble after reconstitution Research Relevance Tesamorelin is used in preclinical studies to investigate the signaling mechanisms of growth hormone regulation, receptor binding, and endocrine feedback. The peptide is intended exclusively for basic research and for analyzing peptide-mediated signal transduction in hormonal regulation. Storage & Handling Store in a cool (2 – 8 °C), dry place. After reconstitution, aliquot and store at −20 °C to maintain peptide structural stability. Certificate of Analysis (COA) Each batch of Tesamorelin is verified through HPLC and mass spectrometry analyses. The corresponding COA is available for download per batch. Notice & Disclaimer This product is intended for research purposes only. Not for human or animal use, and not suitable for diagnostic or therapeutic applications.

€96.99
Details
Ipamorelin (5 mg) – Research peptide
Ipamorelin (5 mg) – Research peptide
Synthetic pentapeptide for studying peptide-mediated secretion signaling pathways in preclinical models. General Description Ipamorelin is a synthetic pentapeptide and selective agonist of the Growth Hormone Secretagogue Receptor (GHS-R). In scientific research environments, it is used to analyze receptor-mediated signaling mechanisms, endocrine cascades, and peptide-induced secretion processes at the molecular level. Due to its high selectivity and stability, Ipamorelin serves as a model compound for studies on peptide–receptor interactions. Chemical Properties Purity: ≥ 99 % (HPLC-tested) Form: lyophilized powder Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ Molecular weight: approx. 711 Da Solubility: water-soluble after reconstitution Research Relevance Ipamorelin is used in preclinical research models to investigate mechanisms of growth hormone secretion, G-protein-coupled signaling pathways, and receptor activation. It is intended exclusively for basic research and structural characterization of peptide-dependent receptor processes. Storage & Handling Store in a cool (2 – 8 °C), dry place. After reconstitution, aliquot and store at −20 °C to ensure peptide stability and structural integrity. Certificate of Analysis (COA) Each batch of Ipamorelin is verified by HPLC and mass spectrometry analyses. The corresponding COA is available for download per batch. Notice & Disclaimer This product is intended for research purposes only. Not for human or animal use, and not suitable for diagnostic or therapeutic applications.

€42.99
Details
CJC-1295 DAC (5 mg) – Research peptide
CJC-1295 DAC (5 mg) – Research peptide
Synthetic peptide analogue for the investigation of signal transduction and secretion mechanisms in preclinical research models. General Description CJC-1295 DAC (Drug Affinity Complex) is a synthetic peptide based on a modified GHRH analogue (Growth Hormone Releasing Hormone). In scientific research environments, it is used to study peptide–receptor binding mechanisms, signal transduction, and hormone-like secretion processes at the molecular level. The DAC modification (Drug Affinity Complex) extends peptide stability and allows detailed analysis of receptor interaction over extended periods. Chemical Properties Purity: ≥ 99 % (HPLC-tested) Form: lyophilized powder Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ Molecular weight: approx. 3647 Da Modification: DAC (Drug Affinity Complex) Solubility: water-soluble after reconstitution Research Relevance In preclinical models, CJC-1295 DAC is used to analyze the dynamics of GHRH analogues, receptor activation, and peptide-mediated signal transduction. It is intended exclusively for basic research and molecular characterization of peptide-based interactions within endocrine signaling networks. Storage & Handling Store in a cool (2 – 8 °C), dry place. After reconstitution, aliquot and store at −20 °C to maintain peptide stability and structural integrity. Certificate of Analysis (COA) Each batch of CJC-1295 DAC is verified through HPLC and mass spectrometry analyses. The corresponding COA is available for download per batch. Notice & Disclaimer This product is intended for research purposes only. Not for human or animal use, and not suitable for diagnostic or therapeutic applications.

€42.99
Details
hGH Fragment 176-191 (5 mg) – Research peptide
hGH Fragment 176-191 (5 mg) – Research peptide
Synthetic peptide fragment of human growth hormone for the investigation of metabolic and cellular signaling mechanisms in research models. General Description The hGH Fragment 176–191 is a synthetically produced peptide corresponding to a specific subsequence of human growth hormone (hGH). In scientific studies, it is used to examine molecular signaling pathways involved in the regulation of energy metabolism and cellular communication processes. Due to its defined structure, the fragment serves as a model peptide for analyzing hormone-like peptide interactions at the molecular level. Chemical Properties Purity: ≥ 99% (HPLC-tested) Form: lyophilized powder Sequence: Leu-Ser-Arg-Leu-Phe-Asp-Asn-Gln-Tyr-Ser-Lys-Leu-Gly-Ala-Phe Molecular weight: approx. 1815 Da Solubility: water-soluble after reconstitution Research Relevance The hGH Fragment 176–191 is used in preclinical research models to analyze biochemical signaling mechanisms, receptor interactions, and cellular response patterns related to peptide-mediated metabolic processes. It is intended exclusively for basic research and structural characterization of peptide–protein interactions. Storage & Handling Store in a cool (2–8 °C), dry place. After reconstitution, aliquot and store at −20 °C to maintain the structural integrity of the peptide. Certificate of Analysis (COA) Each batch of hGH Fragment 176–191 is verified by HPLC and mass spectrometry analyses. The corresponding COA is available for download per batch. Notice & Disclaimer This product is intended for research purposes only. Not for human or animal use, and not suitable for diagnostic or therapeutic applications.

€34.99
Details